Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Infrastructure

Patient Derived Xenograft Platform Ghent

Access & Terms of use

Funding project(s)

Targeting transcription factor addiction in acute leukemia (TaTFAL) (3S002322)

A patient derived xenograft (PDX) platform for in vivo evaluation of novel anticancer therapies (3I003722)